by Rod Raynovich | Jun 28, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Auxilium (AUXL) shares held up today ($24.85 up 0.65%) after a June 28 article questioned the valuation of the stock. Revenues for the last quarter were $45.5M primarily from its Testim testosterone gel, with a loss of $8.6M.Analysts have high expectations for a...